A new discovery by German researchers have said by switching off gene will help to reduce the risk of heart attack by 50% According to researcher, if ANGPTL4 (angiopoietin-like 4) gene were shut off with medications, it could decline the danger of coronary disease.

Heribert Schunkert from Technical University of Munich in Germany who is the lead researcher said, “This discovery makes it considerably easier to develop new medications that simulate the effect of this mutation “This gives follow-on research aiming at reducing heart attacks in the future a concrete goal,The triglycerides, on the other hand, are the second important blood fat, alongside the harmful LDL cholesterol,” Schunkert added.

Total 200,000 participants took part in research; they all are the heart attack patients and healthy people. Out of 200,000,13,000 different genes from a poll were analyzed. Jeanette Erdmann from University of Lübeck in Germany said,“The blood fat triglyceride serves as an energy store for the body.

However, as with LDL (bad) cholesterol, elevated values lead to an increased risk of cardiovascular disease. Low values, by contrast, lower the risk,” “At the same time, we discovered that the body does not even need the ANGPTL4 gene and manages wonderfully without it.

It seems to be superfluous,” Erdmann added Shutting down the gene is a way to reduce risk. “Based on our results, medications now need to be developed that neutralize the effect of the ANGPTL4 gene, thereby, reducing the risk of a heart attack,” Schuinkert explained.